Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.72
Net Income/Share$1.33
Operating CF/Share$-0.78
Free CF/Share$-0.78
Cash/Share$1.65
Book Value/Share$0.76
Tangible Book/Share$0.33
Equity/Share$0.76
Interest Debt/Share$0.45
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$261.08M
Enterprise Value$198.42M
P/E Ratio1.62P/S Ratio3.12P/OCF Ratio-2.78
P/FCF Ratio-2.89
P/B Ratio2.86P/TB Ratio2.86
EV/Sales2.37EV/EBITDA-1.16
Graham Valuation
Graham Number$4.76
Graham Net-Net$-0.41
Profitability
Earnings Yield61.73%FCF Yield-34.54%ROE-574.72%ROIC-122.82%Return on Tangible Assets33.18%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue24.61%
SG&A/Revenue0.00%
R&D/Revenue118.64%
Liquidity & Solvency
Debt/Equity0.46Debt/Assets0.08Debt/Market Cap0.16
Net Debt/EBITDA0.37
Current Ratio1.23Interest Coverage-14.67xIncome Quality-0.58Efficiency
Days Sales Outstanding1094 days
Days Payables Outstanding208 days
Days Inventory17 days
Receivables Turnover0.33x
Payables Turnover1.75x
Inventory Turnover21.30x
Capital Structure
Tangible Assets$38.29M
Working Capital$87.17M
Invested Capital$138.28M
Intangibles/Assets9.58%